NasserAltorkiMD

Aortic Surgery, Cardiovascular Surgery

Professor of Surgery, Cornell University-Weill Medical College

Overview of Dr. Altorki

Dr. Nasser Altorki is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian Brooklyn Methodist Hospital, New York-Presbyterian Queens, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lower Manhattan Hospital. He received his medical degree from Cairo University School of Medicine and has been in practice 40 years. Dr. Altorki accepts several types of health insurance, listed below. He is one of 143 doctors at New York-Presbyterian Hospital and one of 5 doctors at NewYork-Presbyterian/Lower Manhattan Hospital who specialize in Thoracic Surgery. He has more than 100 publications and over 500 citings.

Office
525 E 68th St
# M-404
New York, NY 10065
Book by Phone+1(323) 527-9756

Education & Training

University of ChicagoResidency, Thoracic Surgery, 1985 - 1987
University of ChicagoResidency, Surgery, 1981 - 1985
Washington Hospital CenterInternship, Transitional Year, 1980 - 1981
Cairo University School of MedicineClass of 1977

Certifications & Licensure

FL State Medical License 2020 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 1987 - 2025
IL State Medical License 1981 - 1990
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2014
New York Magazine: Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus Start of enrollment: 2003 Jun 01
Completed
Phase 2
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. Start of enrollment: 2003 Sep 03
Completed
Phase 1
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine Start of enrollment: 2004 Sep 27
Completed
Phase 1
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Active, not recruiting
Phase 3
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer Start of enrollment: 2011 Jun 01
Completed
Phase 1
Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients Start of enrollment: 2012 Feb 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

580 citations
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Enriqueta Felip, Nasser K. Altorki, Caicun Zhou, Tibor Csőszi, Ihor Vynnychenko
Lancet. 2021-10-09
111 citations
Transcriptome Analysis of Individual Stromal Cell Populations Identifies Stroma-Tumor Crosstalk in Mouse Lung Cancer Model
Hyejin Choi, Jianting Sheng, Dingcheng Gao, Fuhai Li, Anna Durrans
Cell Reports. 2015-02-24
163 citations
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
Nasser K. Altorki, Timothy E. McGraw, Alain C. Borczuk, Ashish Saxena, Jeffrey L. Port
The Lancet. Oncology. 2021-06-01

Authored Content

CALGB 140503 Results—an Interview with Nasser AltorkiAugust 2022

Press Mentions

Does Pleural Invasion Lead to Worse Outcomes in Early NSCLC?August 22nd, 2024
Gene Signature May Predict Response to Immunotherapy for Non-Small Cell Lung CancerFebruary 23rd, 2024
Less May Be More When It Comes to Surgery for Early-Stage Lung CancerFebruary 10th, 2023
Join now to see all

Professional Memberships

American College of Surgeons - ACS
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
HIP of New York - Select PPO
MagnaCare PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment